N-Force R&D Services

We empower you to unlock the full potential of RNA innovation through diverse collaboration opportunities

We put our N-Force into motion for and with our partners, accelerating the translation of your science and research into life-changing (sa)mRNA medicines.

R&D Services

End-to-end R&D services

Quantoom as your trusted RNA partner. We put our N-Force into motion for/with our partners allowing to accelerate the translation of your science and research into life-changing (sa)mRNA medicines.

FROM

Disease target or amino acid sequence provided by the partner

Ncode

We design optimally functional (sa)mRNA constructs using our molecular design capabilities

Ntensify®

These RNA sequences are produced based on our Ntensify® process & tested through standard QC

Ncapsulate®

We use our proprietary chemistries & process to formulate the (sa)mRNA drug product

Our team of experts can provide support for tailored RNA activities by putting our N-Force into motion

Molecular design platform
Molecular design platform
Ntensify® Production Systems
Ntensify® Production Systems
Ncapsulate® QCX
Ncapsulate® QCX
TO

Optimally functional drug product containing (sa)mRNA

6 to 8 weeks
R&D Services

We enable you to accelerate your RNA program with our full-stack toolbox

From prophylactic and cancer vaccines to therapeutics, we partner across sequence design, production and formulation to de-risk and accelerate your program.

The pipeline

Programs in development with our partners

Cancer treatment
RNA
CNP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
Preclinical
Clinical
Partners
mRNA
QCX-002
Ncode
Melanoma (shared antigen)
Serum Institute of India
mRNA
QCX-002
Ncode
Melanoma (neoantigen)
Arizona State University
mRNA
QCX-002
Ncode
Colorectal (neoantigen)
Oxford Cancer
mRNA
QCX-002
Ncode
CAR-T
Undisclosed partner
Human vaccines
RNA
CNP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
Preclinical
Clinical
Partners
mRNA
REF CNP
Ncode
Rabies
Internal program
mRNA
REF CNP
Ncode
COVID-19 & Influenza
Horizon Europe
saRNA
QCX-002
Ncode
Influenza H5N1
Serum Institute of India
mRNA
REF CNP
Ncode
Malaria
European Vaccine Initiative
Animal vaccines
RNA
CNP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
POC in target species
Early-phase development
Partners
sa/mRNA
QCX-002
Ncode
PPRV
CVIMThe Pirbright Institute
saRNA
QCX-002
Ncode
Avian Influenza, HPAI
VaxThera
mRNA
QCX-002
Ncode
Feline cancer
Feline cancer
Undisclosed partner
mRNA
QCX-002
Ncode
Inf. disease
Undisclosed partner

Custom CNP* development

Tailored formulation R&D built around your program. We develop custom calixarene nanoparticle (CNP) chemistry to match your specific requirements:

1
Route of administration

Your preferred route — IM, SC, in ovo, and more.

2
Modality

Your preferred modality — mRNA, saRNA, and more.

3
Storage requirement

Your preferred storage profile — lyophilization, RT, and more.

*CNP — calixarene nanoparticle (Ncapsulate®).

Ncapsulate® formulation R&D
Production ServicesComing soon

GMP production for clinical development

GMP-grade RNA production to support your path into clinical trials. This service is being finalized — reach out to discuss your program and be first to know when it launches.

Talk to our team

Let's put our N-Force into motion

Tell us about your RNA program and we will build the right collaboration around it.

Book a callContact us